MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment-Reference-Cited by-同舟云学术

MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment

Published:2017-07-11 Issue:12 Volume:26 Page:1483-1491
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Tervonen Tommi¹^ORCID,Gelhorn Heather²,Sri Bhashyam Sumitra¹,Poon Jiat-Ling²,Gries Katharine S.³,Rentz Anne²,Marsh Kevin¹

Affiliation:

1. Evidera; London UK

2. Evidera; Bethesda MD USA

3. Janssen Global Services; Titusville NJ USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference80 articles.

1. Egbrink MO IJzerman M The value of quantitative patient preferences in regulatory benefit-risk assessment 2014 https://doi.org/10.3402/jmahp.v2.22761

2. Fifty years after thalidomide; what role for drug regulators?;Eichler;Br J Clin Pharmaco,2012

3. Incorporating patient preferences into drug development and regulatory decision making: results from a quantitative pilot study with cancer patients, carers, and regulators;Postmus;Clin Pharmacol Ther,2016

4. FDA Patient preference information-voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling 2016 http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM446680.pdf

5. Tentative guidelines to help choosing an appropriate MCDA method;Guitouni;Eur J Oper Res.,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eumycetoma causative agents: A systematic review to inform the World Health Organization priority list of fungal pathogens;Medical Mycology;2024-06

2. Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens;Medical Mycology;2024-06

3. Multidimensional Thresholding for Individual-Level Preference Elicitation;Value in Health;2024-02

4. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences;Medical Decision Making;2024-01-04

5. Participatory Value Evaluation (PVE): A New Preference-Elicitation Method for Decision Making in Healthcare;Applied Health Economics and Health Policy;2023-12-16